Opioid-induced Bowel Dysfunction (OBD) Pivotal Assessment of Lubiprostone (OPAL)
Clinical trial NCT01298219 · COMPLETED
Trial details
- NCT number
- NCT01298219
- Sponsor
- Sucampo Pharma Americas, LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-12-01
- Primary completion
- 2011-11-01
- Enrollment
- 439
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.